Apricus Biosciences (NASDAQ:APRI)

CAPS Rating: 2 out of 5

A pharmaceutical and medical technology company, which conducts research and development both domestically and abroad on proprietary pharmaceutical products.

Recs

0
Player Avatar thedrew1125 (41.36) Submitted: 2/23/2013 10:58:41 PM : Outperform Start Price: $2.70 APRI Score: -100.12

Gotta give some love to local San Diego companies. That easily-absorbed molecule that they put in their topical treatments will hopefully get some more use.

Featured Broker Partners


Advertisement